Key points are not available for this paper at this time.
Design
Review
Nurses' regulatory roles in FDA trials warrant attention now; leaves open standardization of training and protocols in cardiovascular research.
The article explores the Food and Drug Administration (FDA) Clinical Trial Process for new products in the United States and some unlimited roles nurses provide in this process. Discussions of recent regulatory issues concerning nurses caring for patients in clinical trial are discussed.
No takes yet. Share an insight, caveat, or question.
Sharon L. Snyder (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: